Meropenem PK/PD Variability and Renal Function: “We Go Together”
Background: Meropenem is a carbapenem antibiotic widely employed for serious bacterial infections. Therapeutic drug monitoring (TDM) is a strategy to optimize dosing, especially in critically ill patients. This study aims to show how TDM influences the management of meropenem in a real-life setting,...
Main Authors: | Jacopo Angelini, Simone Giuliano, Sarah Flammini, Alberto Pagotto, Francesco Lo Re, Carlo Tascini, Massimo Baraldo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-08-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/15/9/2238 |
Similar Items
-
Software- and TDM-Guided Dosing of Meropenem Promises High Rates of Target Attainment in Critically Ill Patients
by: Ute Chiriac, et al.
Published: (2023-06-01) -
Pharmacokinetic and Pharmacodynamic Efficacies of Continuous versus Intermittent Administration of Meropenem in Patients with Severe Sepsis and Septic Shock: A Prospective Randomized Pilot Study
by: Hui-Ying Zhao, et al.
Published: (2017-01-01) -
Extended Infusion of Meropenem in Neonatal Sepsis: A Historical Cohort Study
by: Guangna Cao, et al.
Published: (2022-03-01) -
Population PK/PD modelling of meropenem in preterm newborns based on therapeutic drug monitoring data
by: Sergey Zyryanov, et al.
Published: (2023-03-01) -
Mortality of continuous infusion versus intermittent bolus of meropenem: a systematic review and meta-analysis of randomized controlled trials
by: Ming-Ying Ai, et al.
Published: (2024-03-01)